Impact of a pan-sarbecovirus dendritic-cell targeting vaccine on SARS-CoV-2 variants
A new study used in silico approaches for designing a next-generation CD40-targeting vaccine, CD40.
Source: news-medical.net
Stay updated with breaking news from Proteina Affinity. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A new study used in silico approaches for designing a next-generation CD40-targeting vaccine, CD40.